DANNINGER MEDICAL TECHNOLOGY, INC. AND SUBSIDIARY
EXHIBIT 11
COMPUTATION OF NET INCOME PER SHARE
For the three month periods ending September 30, 1996 and 1995
___________________________________________________________________________________________________________________
Three Months Ended September 30, Nine Months Ended September 30,
1996 1995 1996 1995
___________________________________________________________________________________________________________________
Weighted average number of common
shares outstanding 4,776,571 4,687,739 4,754,819 4,621,986
Shares issuable pursuant to
stock option plans and stock warrants,
less shares assumed repurchased at
the average market prices 237,090 254,018
--------- --------- --------- ---------
Weighted average shares outstanding,
including common stock equivalents 5,013,661 4,687,739 5,008,837 4,621,986
--------- --------- --------- ---------
Net income $ 191,000 $ (766,000) $ 474,000 $ (609,000)
--------- --------- --------- ---------
Net income per share $ .04 $ (.16) $ .09 $ (.13)
--------- --------- --------- ---------
__________________________________________________________________________________________________________________
Note: The application of the higher of quarter-end or year end market prices
in calculating fully-diluted earnings per share does not result in a
change to the calculation of primary earnings per share.
14